SM

Seema Monga

Active Director Whole-Time Director DIN 00776330
DIN 00776330 First appointment Jun 1997 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 2 historical roles
Total affiliations 8 Since Jun 1997
Shareholding value •••• Premium profile

About Seema Monga

Data last updated:

Seema Monga is a Whole-Time Director at Rhydburg Pharmaceuticals Ltd (since 2018), Director at Genedrift Global Services Private Limited (since 2022) and Designated Partner at Rhydburg Llp (since 2021), and holds 3 more current directorships. The companies operate in Pharma, Business Services and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹49.39 Cr; the largest is Rhydburg Pharmaceuticals Ltd at ₹48.17 Cr (FY 2024). Earlier, Seema Monga was a Director at Dezzle Pharma Private Limited (from 2012) and Director at Seema Monga's Curls And Curves Pvt Ltd (from 1997).

DIN 00776330
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 20 Jun 1997
Oldest Company Age 39 yrs
Largest company Rhydburg Pharmaceuticals Ltd · ₹48.17 Cr (FY 2024)
Combined revenue ₹49.39 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhydburg Pharmaceuticals Ltd U24231DL1987PLC028434
Whole-Time Director22 Feb 20181987₹48.17 Cr (FY 2024)Active
Director28 Apr 20222022₹1.22 Cr (FY 2024)Active
Rhydburg Llp AAN-0691
Designated Partner12 Jun 20212018Active
Designated Partner10 Jan 20192019Active
Designated Partner20 Apr 20152015Active
Designated Partner27 Feb 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dezzle Pharma Private Limited U51397DL1998PTC096946
Director12 Oct 20121998Converted To Llp
Director20 Jun 19971997Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Seema Monga

Directorship timeline

Open interactive timeline →
Rhydburg Llp
Rhydburg Pharmaceuticals Ltd
Dezzle Pharma Private Limited
Genedrift Global Services Private Limited
Premium access

Shareholding and investment profile for Seema Monga

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Monga

Seema Monga currently holds 6 directorships: Rhydburg Pharmaceuticals Ltd (Whole-Time Director, since 22 Feb 2018, revenue ₹48.17 Cr (FY 2024)); Genedrift Global Services Private Limited (Director, since 28 Apr 2022, revenue ₹1.22 Cr (FY 2024)); Rhydburg Llp (Designated Partner, since 12 Jun 2021); Genedrift Solutions Llp (Designated Partner, since 10 Jan 2019); Seema Monga's Curls And Curves Llp (Designated Partner, since 20 Apr 2015); and 1 more.

Seema Monga was first appointed on 20 Jun 1997 as Director at Seema Monga's Curls And Curves Pvt Ltd. The most recent appointment on record is 28 Apr 2022 at Genedrift Global Services Private Limited.

The 2 current companies of Seema Monga that report revenue have a combined latest revenue of ₹49.39 Cr: Rhydburg Pharmaceuticals Ltd ₹48.17 Cr (FY 2024); Genedrift Global Services Private Limited ₹1.22 Cr (FY 2024).

Seema Monga held 2 earlier board appointments: Dezzle Pharma Private Limited (Director, from 12 Oct 2012); Seema Monga's Curls And Curves Pvt Ltd (Director, from 20 Jun 1997).

The current boards of Seema Monga's companies include Ashok Monga (Rhydburg Pharmaceuticals Ltd), Sovan Lal Subalchand Pal (Rhydburg Pharmaceuticals Ltd), Vinod Thapar (Rhydburg Pharmaceuticals Ltd), Akshay Monga (Genedrift Global Services Private Limited), Madhvi Mehandru (Rhydburg Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available